February 10-11: BIO CEO & Investor Conference 2025. Daniel Vitt, Ph.D., Chief Executive Officer of Immunic, will participate in one-on-one meetings at this conference, taking place in New York.

Listen to Post Strategies to ease the burden Multiple Sclerosis (MS) is a chronic neurological condition that ...

Cigna Group shares slumped after the health insurer reported cost pressures from surprisingly high catastrophic medical ...

During his departure announcement in 2024, Neil thanked his bosses for their patience when he took off “a day or two here and there battling everything from multiple sclerosis and COVID to ...

Multiple sclerosis (MS) is an autoimmune neurological ... Both conditions require a variety of medical tests for a diagnosis. Before you begin any tests, you may be able to distinguish your ...

the programme is targeted toward treatment of neurological diseases with high unmet medical need, with an initial focus on multiple sclerosis (MS). Demyelination in MS occurs when the immune ...

PTD802 is aimed at promoting remyelination in individuals with neurological conditions, particularly multiple sclerosis. Credit: New Africa/Shutterstock. Pheno Therapeutics has gained clinical trial ...

enriched data will enable Nira Medical to collaborate with life sciences companies, accelerating drug discovery and advancing care for patients, starting in multiple sclerosis While electronic ...

When it comes to the outlook for multiple sclerosis (MS), there’s both good ... academic research institutions, and medical journals and associations. We only use quality, credible sources ...

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS ... said Hannah Silverman, a UCSF medical student, who is the first author of the ...

A new study by UC San Francisco has found that menopause revs up the progression of multiple sclerosis (MS ... said Hannah Silverman, a UCSF medical student, who is the first author of the ...